Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997111 · ClinicalTrials.gov registry record · NA
PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
A NA study of Thrombosis and Platelet Function, sponsored by St. Louis University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT02997111 is a NA study of Thrombosis and Platelet Function that has completed, run by St. Louis University. The registered enrollment target is 13 participants, below the 470-participant average among 28 other Thrombosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02997111, a NA study of Thrombosis and Platelet Function, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the responsiveness of the Platelet Function Analyzer (PFA-100) to the effect of energy drinks on platelet function. Participants' will have blood drawn prior to and 60 minutes after ingesting 250ml of a commercially available sugar-free energy drink.
Conditions Studied
Interventions
- DEVICE PFA-100
Study Locations (1)
Missouri
- Saint Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2017-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02997111
The ClinicalTrials.gov registry entry for NCT02997111 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 470-participant average among 28 other Thrombosis trials with a reported enrollment target (97% lower). The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which PFA-100 is the first listed.
NCT02997111 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02997111 about?
NCT02997111 is a clinical study titled "PFA-100 Responsive to Effect of Energy Drinks on Platelet Function". This study evaluates the responsiveness of the Platelet Function Analyzer (PFA-100) to the effect of energy drinks on platelet function. Participants' will have blood drawn prior to and 60 minutes after ingesting 250ml of a commercially available sugar-free energy drink.
What is the current status of trial NCT02997111?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-02-14. Estimated completion is 2017-06-20.
What conditions does trial NCT02997111 study?
This clinical trial studies the following conditions: Thrombosis, Platelet Function.
What interventions are being tested in trial NCT02997111?
The interventions under investigation include: PFA-100 (DEVICE).
Who is sponsoring clinical trial NCT02997111?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02997111 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
COMPLETED · NA
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.